入组时间：2022.09

教育经历：

2014.09-2019.06 南华大学 学士

2019.09-2022.06 中南大学 硕士

2023.02-至今 中科院上海药物所-宁波诺丁汉大学联合培养 博士

研究方向：肿瘤免疫治疗

代表性研究成果：

1. Shiqin Li; Sijia Li; Cyrollah Disoma; Rong Zheng; Mei Zhou; Aroona Razzaq; Pinjia Liu; Yuzheng Zhou; Zijun Dong; Ashuai Du; Jian Peng; Liqiang Hu; Jufang Huang; Pinghui Feng; Taijiao Jiang; Zanxian Xia ; SARS-CoV-2: Mechanism of infection and emerging technologies for future prospects., Reviews in Medical Virology, 2020, 31(2): e2168（期刊论文）

2. Ashuai Du; Shiqin Li; Yuzheng Zhou; Cyrollah Disoma; Yujie Liao; Yongxing Zhang; Zongpeng Chen; Qinglong Yang; Pinjia Liu; Sixu Liu; Zijun Dong; Aroona Razzaq; Siyi Tao; Xuan Chen; Yuxin Liu; Lunan Xu; Qianjun Zhang; Shanni Li; Jian Peng; Zanxian Xia ; M6A-Mediated Upregulation of CircMDK Promotes Tumorigenesis and Acts as a Nanotherapeutic Target in Hepatocellular Carcinoma., Molecular Cancer , 2022, 21(1): 1109（期刊论文）

3. Xin Wu; Shiqin Li; Dongjie Chen; Guiping Zheng; Zhaohua Zhang; Zian Li; Xiaoying Sun; Qiangqiang Zhao; Jingjuan Xu ; An inflammatory response-related gene signature associated with immune status and prognosis of acute myeloid leukemia., American Journal of Translational Research , 2022, 14(7): 4898-4017（期刊论文）

4. Ashuai Du; Rong Zheng; Cyrollah Disoma; Shiqin Li; Zongpeng Chen; Sijia Li; Pinjia Liu; Yuzheng Zhou; Yilun Shen; Sixu Liu; Yongxing Zhang; Zijun Dong; Qinglong Yang; Moyed Alsaadawe; Aroona Razzaq; Yuyang Peng; Xuan Chen; Liqiang Hu; Jian Peng; Qianjun Zhang; Taijiao Jiang; Long Mo; Shanni Li; Zanxian Xia ; Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2, International Journal of Biological Macromolecules , 2021, 176: 1-12（期刊论文）

5. 夏赞贤; 杜阿帅; 李诗琴 ; 环状RNAcircMDK及其应用和肝癌治疗制剂, 2022-03-28, 中国, CN202210313271.7（专利）

所获奖励荣誉：

1. 中南大学硕士研究生易定宏奖励金

2. 中南大学2022届优秀毕业生

3. 中南大学研究生优秀学生

4. 一等学业奖学金